This paper is only available as a PDF. To read, Please Download here.
Recent reports suggest an improved survival following resection for patients with pancreatic carcinoma. However, the prognosis for patients with lymph nodes metastases remains uncertain. The purpose of this study was to determine if the presence of lymph node metastases significantly alters survival in patients with otherwise potentially curable pancreatic carcinoma.
Patients and Methods
Between 1970 and 1995, 401 patients with pancreatic adenocarcinoma, including 327 patients with pancreatic head tumors, were evaluated and treated.
One hundred (31%) patients underwent pancreatoduodenectomy. Operative mortality was 3% and morbidity was 22%. Median survival for 97 patients discharged from the hospital following resection was 14 months (range 2 to 293). The estimated 1-, 2-, and 5-year survivals were 61%, 43%, and 20%, respectively. Median survival was 11.5 months (range 2 to 87) for patients with positive lymph nodes (n = 56) and 24 (range 0 to 293) months for patients with negative lymph nodes (n = 41; P = 0.0003). Ten patients (10%) survived longer than 5 years, and 9 (90%) of them had negative lymph nodes. Elderly patients (≥70 years) had a median survival twice as long as younger patients (24 versus 12 months, P = 0.03).
Lymph node metastases are found in 56% of patients undergoing resection. Pancreatoduodenectomy can be performed with low operative mortality in patients of all ages. It offers good palliation for patients with lymph nodes metastases and encouraging long-term survival rates as well as a chance for cure in patients with negative lymph nodes.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The American Journal of Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Cancer statistics, 1996.CA Cancer J Clin. 1996; 65: 5-27
- Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting.J Am Coll Surg. 1995; 181: 483-503
- Pancreato-gastrostomy: a safe drainage procedure after pancreatoduodenectomy.Surgery. 1990; 108: 641-647
- Pancreaticoduodenectomy for cancer of the head of the pancreas.Ann Surg. 1995; 221: 721-733
- Long-term survival after resection for ductal adenocarcinoma of the pancreas: is it really improving?.Ann Surg. 1995; 221: 59-66
- Prognostic indicators for survival after resection of pancreatic adenocarcinoma.Am J Surg. 1993; 165: 68-73
- Survival after pancreatoduodenectomy.Ann Surg. 1990; 211: 447-458
- Factors influencing survival after resection for ductal adenocarcinoma of the pancreas.Ann Surg. 1986; 203: 403-407
- Collective review of small carcinomas of the pancreas.Ann Surg. 1986; 203: 77-81
- Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct.Ann Surg. 1989; 210: 544-556
- Surgery for exocrine pancreatic cancer: who are the 5-and 10-year survivors?.Oncology. 1995; 52: 353-359
- Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region.Cancer. 1995; 75: 2069-2076
- Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head.Am J Surg. 1996; 171: 118-125
- Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy.Ann Surg. 1996; 223: 147-153
- Significance of tumor spread in adenocarcinoma of the ampulla of Vater.Am J Surg. 1989; 158: 593-597
- Improving resectability and survival in patients with primary duodenal carcinoma.Am J Surg. 1993; 166: 626-631
- Characteristics of cystic neoplasms of the pancreas and results of aggressive surgical treatment.Am J Surg. 1992; 164: 437-442
- Cancer of the pancreas: diagnostic accuracy and survival statistics.Cancer. 1978; 42: 2494-2506
- Cancer of the pancreas: 50 years of surgery.Cancer. 1987; 60: 2284-2303
- The effects of regionalization on cost and outcome for one general high-risk surgical procedure.Ann Surg. 1995; 221: 43-49
- Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy.Ann Surg. 1995; 222: 638-645
- The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma.Surg Gynecol Obstet. 1970; 130: 1049-1053
- Adenocarcinoma of the pancreas: a statistical analysis of biliary bypass vs Whipple resection in good risk patients.Ann Surg. 1975; 182: 715-721
- Long-term survival after curative resection for pancreatic ductal adenocarcinoma: clinicopathologic analysis of 5-year survivors.Ann Surg. 1996; 223: 273-279
- Carcinoma of the pancreas and periampullary region: a study of 279 patients.Ann Surg. 1979; 189: 129-138
- Pancreaticoduodenectomy for malignant pancreatic and periampullary neoplasms in elderly patients.Am J Surg. 1991; 162: 532-536
**Presented at the 48th Annual Meeting of the Southwestern Surgical Congress, Scottsdale, Arizona, April 28–May 1, 1996.
© 1996 Excerpta Medica, Inc. All rights reserved. Published by Elsevier Inc.